Concepedia

Pieter D. de Koning

PD

Statistics

Publications

10

Citations

433

H-Index

10

Active since

1999

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

Dow Chemical (United Kingdom)

Pieter D. de Koning is an author at Pfizer (United Kingdom) specializing in chemistry, natural sciences, and organic chemistry.

Publications per year

1999–2011

10

Publications

10

An Enantioselective Synthesis of (<i>S</i>)-(+)-3-Aminomethyl-5-methylhexanoic Acid via Asymmetric Hydrogenation

Mark J. Burk, Pieter D. de Koning, Todd M. Grote et al. · The Journal of Organic Chemistry · 2003 · 139 citations

, , +12

Fit-for-Purpose Development of the Enabling Route to Crizotinib (PF-02341066)

Pieter D. de Koning, Douglas McAndrew, Robert Moore et al. · Organic Process Research & Development · 2011 · 89 citations

, , +12

Bidirectional Asymmetric Allylboration. A Convenient Asymmetric Synthesis of <i>C</i><sub>2</sub>-Symmetric 3-Methylenepentane-1,5-diols and Rapid Access to <i>C</i><sub>2</sub>-Symmetric Spiroketals

Anthony G. M. Barrett, D. Christopher Braddock, Pieter D. de Koning et al. · The Journal of Organic Chemistry · 1999 · 60 citations

, , +11

The use of Dodt as a Non-Malodorous Scavenger in Fmoc-Based Peptide Synthesis

António P. S. Teixeira, Willemien E. Benckhuijsen, Pieter D. de Koning et al. · Protein and Peptide Letters · 2002 · 33 citations

, , +11

Use of Achiral (Diphosphine)RuCl<sub>2</sub>(Diamine) Precatalysts as a Practical Alternative to Sodium Borohydride for Ketone Reduction

Pieter D. de Koning, Mark Jackson, Ian C. Lennon · Organic Process Research & Development · 2006 · 29 citations

, , +13

1–5 of 10